Suxamethonium invoice - Neuraxapharm letter of intent (LOI)

NHS EnglandcontractContracts FinderRef tender_237299/889269SME suitableVCSE suitablecomplete
View buyer

Estimated value

£43k

Awarded value

£43k

Awarded 22 Apr 2020

Suppliers

1

Lots

1

1 awarded

Published

23 Sept 2020

Deadline 31 Jul 2020

Other contracts from NHS England· 10

Most recent notices published by the same contracting authority.

View buyer profile →
TitleTypeValuePublished
Matrix - Desk Booking Systemcall off£105k08 May 2026
Telephony 0300 Numbers Renewal (Gamma) 2026 - 2028call off£17k08 May 2026
ID&V Checking Servicecontract£150k08 May 2026
Xerox Managed Print renewal 26/27call off£127k08 May 2026
Manage Engine ServiceDesk Plus Licencescall off£29k08 May 2026
Ccube EDRMS C302203 Annual Maintenance and Support 2025 - 2026contract£105k08 May 2026
Clinicals Run Maintain Transformcall off£38.0m10 Apr 2026
Specialised Pharmaceutical Logistics and Warehouse Services for Vaccination & Immunisation Programmescontract07 Apr 2026
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiativescontract07 Apr 2026
CPIT System Integration to NHSE RAVScontract£500k01 Apr 2026

Other contracts awarded to Neuraxpharm UK Ltd· 10

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →
TitleTypeValuePublished
NHS National Branded Interim - 1 June 2026contract22 May 2026
NHS National Branded Interim - 1 June 2026contract16 Apr 2026
NHS National Generic Pharmaceuticals - Wave 15ccontract26 Feb 2026
NHS National Generic Pharmaceuticals - Wave 15ccontract14 Jan 2026
Generic, Branded Generic & Proprietary Medicinal Products - Group 16contract21 Aug 2025
NP30925 Psychiatry and Neurology Medicinescontract18 Aug 2025
NHS National Generic Pharmaceuticals Wave 15bcontract04 Aug 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025contract22 Apr 2025
NHS National Generic Pharmaceuticals Wave 15acontract18 Dec 2024
Generic, Branded Generic & Proprietary Medicinal Products - Group 14contract15 Aug 2024